Pioglitazone
Product Images NDC 68151-3792

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Pioglitazone (NDC 68151-3792). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Carilion Materials Management, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pioglitazone Hydrochloride Chemical Structure (3c52f60a 9068 4606 8056 02cebd614d74 01)

Chemical structure of pioglitazone hydrochloride showing its molecular components including a pyridine ring, aromatic ring with an ether linkage, and a thiazolidinedione ring with a hydrochloride group.*

FDA Label Image

Figure1 (3c52f60a 9068 4606 8056 02cebd614d74 02)

A line graph showing mean values over a 26-week period, with data series for Placebo, 15 mg, 30 mg, and 45 mg dosages. The x-axis represents weeks from 0 to 26, and the y-axis represents the mean values ranging approximately from -2.0 to 1.0. The Placebo group shows positive mean values while the dosage groups show decreasing mean values over time.*

FDA Label Image

Label Image (68151 3792)

Label for Pioglitazone HCL 15 mg tablets manufactured by TEVA. The label indicates prescription use only and includes a lot number, expiration date, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.